Global Locator
Genzyme Websites
Health Care Professionals
Company
Products
Research
Patients
Responsibility
Careers
News
About Genzyme
Company Leadership
Business Units
News
Press Contacts
Subscribe to News
Recognition and Awards
Working With Genzyme
Global Reach
Download Genzyme Materials
October 12, 2012 09:10 AM Eastern Daylight Time
Genzyme Presents Second Phase III Study of Once-daily Oral AUBAGIO® (teriflunomide) Confirming Significant Impact on Disability
Download
Small
JPEG, 406x163, 23.7 KB
Preview
JPEG, 144x57, 5.9 KB
Thumbnail
JPEG, 120x47, 4.8 KB
Smart Multimedia Gallery
About MS Fact Sheet
View and Share Photo
Download Full Size
Download Small
Share
Facebook
Twitter
LinkedIn
Delicious
Reddit
StumbleUpon
Digg
MySpace
Newsvine
Google Bookmark
Yahoo! Bookmark
Email
All News
|
News with Multimedia
>
Press Release: Genzyme Presents Second Phase III Study of Once...
infoBox
LinkedIn
Yahoo! Buzz
Facebook
Twitter
Delicious
DIGG